229 related articles for article (PubMed ID: 32244885)
1. Use of STAT6 Phosphorylation Inhibitor and Trimethylglycine as New Adjuvant Therapies for 5-Fluorouracil in Colitis-Associated Tumorigenesis.
Mendoza-Rodríguez MG; Sánchez-Barrera CÁ; Callejas BE; García-Castillo V; Beristain-Terrazas DL; Delgado-Buenrostro NL; Chirino YI; León-Cabrera SA; Rodríguez-Sosa M; Gutierrez-Cirlos EB; Pérez-Plasencia C; Vaca-Paniagua F; Meraz-Ríos MA; Terrazas LI
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32244885
[TBL] [Abstract][Full Text] [Related]
2. Lack of STAT6 Attenuates Inflammation and Drives Protection against Early Steps of Colitis-Associated Colon Cancer.
Leon-Cabrera SA; Molina-Guzman E; Delgado-Ramirez YG; Vázquez-Sandoval A; Ledesma-Soto Y; Pérez-Plasencia CG; Chirino YI; Delgado-Buenrostro NL; Rodríguez-Sosa M; Vaca-Paniagua F; Ávila-Moreno F; Gutierrez-Cirlos EB; Arias-Romero LE; Terrazas LI
Cancer Immunol Res; 2017 May; 5(5):385-396. PubMed ID: 28385737
[TBL] [Abstract][Full Text] [Related]
3. Loss of Stat6 affects chromatin condensation in intestinal epithelial cells causing diverse outcome in murine models of inflammation-associated and sporadic colon carcinogenesis.
De Oliveira T; Ramakrishnan M; Diamanti MA; Ziegler PK; Brombacher F; Greten FR
Oncogene; 2019 Mar; 38(11):1787-1801. PubMed ID: 30353167
[TBL] [Abstract][Full Text] [Related]
4. The c-MYC-ABCB5 axis plays a pivotal role in 5-fluorouracil resistance in human colon cancer cells.
Kugimiya N; Nishimoto A; Hosoyama T; Ueno K; Enoki T; Li TS; Hamano K
J Cell Mol Med; 2015 Jul; 19(7):1569-81. PubMed ID: 25689483
[TBL] [Abstract][Full Text] [Related]
5. STAT6 activation in ulcerative colitis: a new target for prevention of IL-13-induced colon epithelial cell dysfunction.
Rosen MJ; Frey MR; Washington MK; Chaturvedi R; Kuhnhein LA; Matta P; Revetta FL; Wilson KT; Polk DB
Inflamm Bowel Dis; 2011 Nov; 17(11):2224-34. PubMed ID: 21308881
[TBL] [Abstract][Full Text] [Related]
6. Liposomal prednisolone phosphate potentiates the antitumor activity of liposomal 5-fluorouracil in C26 murine colon carcinoma in vivo.
Patras L; Sylvester B; Luput L; Sesarman A; Licarete E; Porfire A; Muntean D; Drotar DM; Rusu AD; Nagy AL; Catoi C; Tomuta I; Vlase L; Banciu M; Achim M
Cancer Biol Ther; 2017 Aug; 18(8):616-626. PubMed ID: 28696813
[TBL] [Abstract][Full Text] [Related]
7. Novel evidence for an oncogenic role of microRNA-21 in colitis-associated colorectal cancer.
Shi C; Yang Y; Xia Y; Okugawa Y; Yang J; Liang Y; Chen H; Zhang P; Wang F; Han H; Wu W; Gao R; Gasche C; Qin H; Ma Y; Goel A
Gut; 2016 Sep; 65(9):1470-81. PubMed ID: 25994220
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of chemosensitivity in 5-fluorouracil-resistant colon cancer cells with carcinoembryonic antigen-specific RNA aptamer.
Lee JH; Lee SW
Mol Biol Rep; 2019 Aug; 46(4):3835-3842. PubMed ID: 31028570
[TBL] [Abstract][Full Text] [Related]
9. 23-Hydroxybetulinic acid attenuates 5-fluorouracil resistance of colorectal cancer by modulating M2 macrophage polarization via STAT6 signaling.
Fan Z; Cui Y; Chen L; Liu P; Duan W
Cancer Immunol Immunother; 2024 Mar; 73(5):83. PubMed ID: 38554148
[TBL] [Abstract][Full Text] [Related]
10. Stat6 activity-related Th2 cytokine profile and tumor growth advantage of human colorectal cancer cells in vitro and in vivo.
Li BH; Xu SB; Li F; Zou XG; Saimaiti A; Simayi D; Wang YH; Zhang Y; Yuan J; Zhang WJ
Cell Signal; 2012 Mar; 24(3):718-25. PubMed ID: 22108090
[TBL] [Abstract][Full Text] [Related]
11. STAT6 Is Critical for the Induction of Regulatory T Cells In Vivo Controlling the Initial Steps of Colitis-Associated Cancer.
Delgado-Ramirez Y; Ocaña-Soriano A; Ledesma-Soto Y; Olguín JE; Hernandez-Ruiz J; Terrazas LI; Leon-Cabrera S
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919941
[TBL] [Abstract][Full Text] [Related]
12. Down-regulating IL-6/GP130 targets improved the anti-tumor effects of 5-fluorouracil in colon cancer.
Li S; Tian J; Zhang H; Zhou S; Wang X; Zhang L; Yang J; Zhang Z; Ji Z
Apoptosis; 2018 Jun; 23(5-6):356-374. PubMed ID: 29777330
[TBL] [Abstract][Full Text] [Related]
13. Epithelial vanin-1 controls inflammation-driven carcinogenesis in the colitis-associated colon cancer model.
Pouyet L; Roisin-Bouffay C; Clément A; Millet V; Garcia S; Chasson L; Issaly N; Rostan A; Hofman P; Naquet P; Galland F
Inflamm Bowel Dis; 2010 Jan; 16(1):96-104. PubMed ID: 19572375
[TBL] [Abstract][Full Text] [Related]
14. Thymoquinone subdues tumor growth and potentiates the chemopreventive effect of 5-fluorouracil on the early stages of colorectal carcinogenesis in rats.
Kensara OA; El-Shemi AG; Mohamed AM; Refaat B; Idris S; Ahmad J
Drug Des Devel Ther; 2016; 10():2239-53. PubMed ID: 27468227
[TBL] [Abstract][Full Text] [Related]
15. Targeting the Stat6 pathway in tumor-associated macrophages reduces tumor growth and metastatic niche formation in breast cancer.
Binnemars-Postma K; Bansal R; Storm G; Prakash J
FASEB J; 2018 Feb; 32(2):969-978. PubMed ID: 29066614
[TBL] [Abstract][Full Text] [Related]
16. Helminth-derived molecules inhibit colitis-associated colon cancer development through NF-κB and STAT3 regulation.
Callejas BE; Mendoza-Rodríguez MG; Villamar-Cruz O; Reyes-Martínez S; Sánchez-Barrera CA; Rodríguez-Sosa M; Delgado-Buenrostro NL; Martínez-Saucedo D; Chirino YI; León-Cabrera SA; Pérez-Plasencia C; Vaca-Paniagua F; Arias-Romero LE; Terrazas LI
Int J Cancer; 2019 Dec; 145(11):3126-3139. PubMed ID: 31407335
[TBL] [Abstract][Full Text] [Related]
17. Dclk1 Inhibition Cancels 5-FU-induced Cell-cycle Arrest and Decreases Cell Survival in Colorectal Cancer.
Suehiro Y; Takemoto Y; Nishimoto A; Ueno K; Shirasawa B; Tanaka T; Kugimiya N; Suga A; Harada E; Hamano K
Anticancer Res; 2018 Nov; 38(11):6225-6230. PubMed ID: 30396941
[TBL] [Abstract][Full Text] [Related]
18. A novel STAT6 inhibitor AS1517499 ameliorates antigen-induced bronchial hypercontractility in mice.
Chiba Y; Todoroki M; Nishida Y; Tanabe M; Misawa M
Am J Respir Cell Mol Biol; 2009 Nov; 41(5):516-24. PubMed ID: 19202006
[TBL] [Abstract][Full Text] [Related]
19. Concerted actions of ameliorated colitis, aberrant crypt foci inhibition and 15-hydroxyprostaglandin dehydrogenase induction by sonic hedgehog inhibitor led to prevention of colitis-associated cancer.
Kangwan N; Kim YJ; Han YM; Jeong M; Park JM; Hahm KB
Int J Cancer; 2016 Mar; 138(6):1482-93. PubMed ID: 26476372
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of transient receptor potential channel 5 reverses 5-Fluorouracil resistance in human colorectal cancer cells.
Wang T; Chen Z; Zhu Y; Pan Q; Liu Y; Qi X; Jin L; Jin J; Ma X; Hua D
J Biol Chem; 2015 Jan; 290(1):448-56. PubMed ID: 25404731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
